Every woman who lives past midlife will experience menopause, which, by definition, is
complete cessation of ovarian function. This process might occur spontaneously (natural …

Plant-derived compounds have recently attracted greater interest in the field of new
therapeutic agent development. These compounds have been widely screened for their …

This care pathway from the European Menopause and Andropause Society (EMAS)
provides an updated pathway for monitoring and guidance of women at midlife, focusing on …

Menopause is associated with hormonal changes, which could accelerate or lead to
sarcopenia. Functional impairment and physical disability are the major consequences of …

BACKGROUND: Menopause is part of working women's lives. In Western countries, labour
market patterns are changing rapidly: women's labour participation has increased, the …

Introduction The menopause, or the cessation of menstruation, is a stage of the life cycle
which will occur in all women. Managing perimenopausal and postmenopausal health is a …

Introduction Dyslipidemias are common and increase the risk of cardiovascular disease. The
menopause transition is associated with an atherogenic lipid profile, with an increase in the …

Vasomotor symptoms affect as many as 80% of midlife women, but only about one in four
women receive treatment due to many factors. Menopausal hormone therapy remains the …

The menopausal transition, or perimenopause, is characterized by menstrual irregularities,
vasomotor symptoms, sleep disturbances, mood symptoms, and urogenital tract atrophy …

Introduction: Although international clinical practice guidelines recognize a continued role
for menopausal hormone therapy (HT), particularly for symptomatic women< 60 years of age …